| Literature DB >> 34234168 |
Nayane Chagas Carvalho Alves1, Sirley Raiane Mamede Veloso1, Silmara de Andrade Silva1, Andressa Cartaxo de Almeida1, Christianne Tavares Velozo Telles1, Kaline Romeiro1, Gabriela Queiroz de Melo Monteiro2, Diana Santana de Albuquerque1.
Abstract
The purpose of this systematic review was to analyze the influence of occlusal reduction on the postoperative pain levels after endodontic treatment (instrumentation and obturation of the root canal system). This review followed the PRISMA statement and was registered at PROSPERO (CRD42018107918). Two independent reviewers searched the Lilacs, Cochrane Library, PubMed (Medline), Web of Science, Scopus, Scielo, and ScienceDirect for articles published until April 2021. The research question was, "Does occlusal reduction decrease postoperative pain in endodontically treated teeth?". Only randomized clinical trials were included. The RevMan 5 program was used for meta-analysis, calculating the relative risk (RR) and 95% confidence interval (CI) of the dichotomous outcome (presence or absence of pain). The search strategies retrieved 4114 studies. Twelve studies were included for qualitative analysis and nine for quantitative analysis. The meta-analysis results did not reveal a significant difference in the reduction of postoperative pain levels for endodontic instrumentation at 6, 12, 24, 48 h and for endodontic obturation at 6 or 12 h after occlusal reduction. According to the GRADE tool, the analyzed outcome was classified as having a moderate level of certainty. It is concluded that occlusal reduction does not interfere with postoperative pain levels after endodontic treatment.Entities:
Year: 2021 PMID: 34234168 PMCID: PMC8263790 DOI: 10.1038/s41598-021-93119-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Electronic databases used and search strategy.
| Database | Search strategy |
|---|---|
| LILACS | ((tw:(endodontology)) OR (tw:(endodontics)))) AND (tw:(Postoperative Pain)) OR (tw:(Postoperative Pains)) |
| Cochrane Library | ((((postoperative pains) OR postoperative pain) OR postoperative pain)) AND ((endodontics) OR Endodontology) |
| PubMed (Medline) | ((((endodontics[MeSH Terms]) OR endodontology[Title/Abstract]) OR endodontics[Title/Abstract])) AND (((postoperative pain[MeSH Terms]) OR Postoperative Pain[Title/Abstract]) OR Postoperative Pains[Title/Abstract]) |
| Web of Science | TI = ("Postoperative Pain" OR "Postoperative Pains") AND TS = (Endodontics OR Endodontology) |
| Scopus | TITLE-ABS-KEY((“Postoperative Pain”) OR (“Postoperative Pain”)) AND TITLE-ABS-KEY((Endodontics) OR (Endodontology)) |
| Scielo | (ti:(“Dor Pós-Operatória” OR “Dolor Posoperatorio” OR “Pain, Postoperative”)) AND (ti:((Endodontia OR Endodoncia OR Endodontics)) |
| ScienceDirect | Title, abstract or keywords((((postoperative pains) OR postoperative pain) OR postoperative pain[MeSH Terms])) AND ((endodontics) OR Endodontology) |
The electronic searches were performed until April 2021 with no restrictions of the start date. Studies published in English, Spanish, and Portuguese were included.
MeSH medical subject heading.
Figure 1Preferred reporting items for systematic reviews and meta-analyses flow diagram.
Evidence table summarizing the characteristics of the included studies.
| Study | Diagnosis | Teeth | Instrumentation protocol | Restorative material | Postoperative pain assessment | Groups (n) | Results | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Preparation | NaOCl concentration (%) | Intracanal medication (ICM) | Stage of endodontic treatment | Type of scale | Experimental period | Control group (occlusal adjustment) | Study group (occlusal reduction) | |||||
| Ahmed et al. (2020)[ | Symptomatic irreversible pulpitis with sensitivity to percussion | Mandibular posterior teeth | Crown-down technique Manual files and Revo-S rotary system | 2.5 | No ICM (sterile cotton pellet) | After instrumentation: MD-Temp (based on zinc oxide) | After instrumentation | Numerical rating scale | After instrumentation: 6, 12, 24 and 48 h | 154 (using articulating paper) | 154 (not report the extent of occlusal reduction) | Significant results of reduction in postoperative pain levels 12 and 24 h after instrumentation |
| After obturation: Final coronal restoration. Not reported | After obturation | After obturation: 6 and 12 h | ||||||||||
| Arslan et al.[ | Symptomatic apical periodontitis | Molars | ProTaper Universal and K files in some cases | 1.25 | – | Fluid resin and nanohybrid resin | After obturation | Visual analog scale | 1st, 3rd, 5th and 7th day | 11 (using a computerized analysis system) | 13 (not report the extent of occlusal reduction) | No statistical significance |
| Asghar et al. (2014)[ | Symptomatic irreversible pulpitis | Posterior maxillary and mandibular teeth | Gates-Glidden and K files | 1.3 | Calcium hydroxide paste | Provisional sealing. Not reported | After instrumentation | Visual analog scale | 1st, 2nd and 3rd day | 55 (using articulating paper) | 55 (occlusal surface reduced by 1 mm) | No statistical significance |
| Creech et al. (1984)[ | Not reported | Posterior teeth | Step-back technique | 2.5 | No ICM (sterile cotton pellet) | Provisional sealing: Cavit (based on zinc oxide) | After instrumentation | Questionnaire | 4, 8, 24, 36 and 48 h | 25 (using articulating paper) | 24 (occlusal surface reduced by 0.5 mm) | No statistical significance |
| Emara et al. (2019)[ | Symptomatic irreversible pulpitis; symptomatic apical periodontitis | Mandibular posterior teeth | Crown-down technique Manual files and Revo-S rotary system | 2.5 | No ICM (sterile cotton pellet) | After instrumentation: MD-Temp (based on zinc oxide) | After instrumentation | Visual analog scale | After instrumentation: 6, 12, 24 and 48 h | 22 (using articulating paper) | 22 (not report the extent of occlusal reduction) | Significant results of reduction in postoperative pain levels 12 h after instrumentation and obturation |
| After obturation: Resin and/or ceramic crown | After obturation | After obturation: 6 and 12 h | ||||||||||
| Parirokh et al. (2013)[ | Symptomatic irreversible pulpitis | Premolar and molars | Manual files, Gates-Glidden drills and HERO 642 rotary instruments | 1.3 | Calcium hydroxide paste | Provisional sealing: Cotosol (based on zinc oxide) | After instrumentation | Visual analog scale | 6, 12, 18, 24 h , 2nd, 3rd, 4th, 5th and 6th day | 21 (using articulating paper) | 25 (occlusal surface reduced by 1 mm) | No statistical significance |
| Raza et al. (2016)[ | Symptomatic irreversible pulpitis | posterior maxillary and mandibular teeth | Gates-Glidden and K files | 1.3 | Calcium hydroxide paste | Provisional sealing. Not reported | After instrumentation | Visual analog scale | 24 h | 55 (using articulating paper) | 55 (occlusal surface reduced by 1 mm) | No statistical significance |
| Rosenberg et al. (1998)[ | Without specifications | Posterior teeth | Step-back technique Manual files | 2 | No ICM (sterile cotton pellet) | Provisional sealing: Cavit (based on zinc oxide) | After instrumentation | Questionnaire | Over 48 h | Not reported (using articulating paper) | Not reported (occlusal surface reduced by 0.5 to 1.0 mm) | Occlusal reduction aids in the prevention of postoperative pain in teeth with vital pulp, percussion sensitivity, preoperative pain, and/or absence of periradicular radiolucency |
| Sheikh et al. (2015)[ | Symptomatic irreversible pulpitis | Posterior teeth | Manual instruments, Gates-Glidden drills and ProTaper F1 or F2 rotary instruments | 3 | Calcium hydroxide paste | Provisional sealing: Cavit (based on zinc oxide) | After instrumentation | Visual analog scale | 6, 12, 18, 24 h, 2nd, 3rd, 4th, 5th and 6th day | 201 (using articulating paper) | 201 (occlusal surface reduced by 1 mm) | The mean pain score was significant 6 days after instrumentation |
| Viana et al. (2020)[ | Symptomatic irreversible pulpitis | Maxillary and mandibular molars | Proglider and WaveOne Gold systems | 2.5 | – | Provisional sealing: Glass ionomer | After obturation | Verbal rating scale and numerical rating scale | 6, 24 and 72 h | 40 (using articulating paper) | 38 (not report the extent of occlusal reduction) | No statistical significance |
| Zaman and Ahmed (2016)[ | Symptomatic irreversible pulpitis | posterior maxillary and mandibular teeth | Gates-Glidden and K files | 2.5 | Calcium hydroxide paste | Provisional sealing: Cavit (based on zinc oxide) | After instrumentation | Visual analog scale | 24 h, 2nd, 3rd, 4th, 5th and 6th day | 125 (using articulating paper) | 125 (occlusal surface reduced by 1 mm) | The mean pain score was significant 6 days after instrumentation |
| Zeidan (2016)[ | Symptomatic irreversible pulpitis | Premolars | Manual instruments and WaveOne Primary | 2 | Endoseptone | Resin-reinforced glass ionomer | After instrumentation | Verbal rating scale | 12, 24 and 48 h | 20 (using articulating paper) | 20 (occlusal surface reduced by 1 mm) | No statistical significance |
Figure 2Risk of bias assessment of the included studies.
Grade of Recommendation, Assessment, Development, and Evaluation (GRADE) based on the characteristics of studies included in the systematic review and meta-analysis.
| Certainty assessment | No. of patients | Effect | Result | Certainty | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | Occlusal reduction | Occlusal adjustment | Relative (95% CI) | Absolute (95% CI) | Risk ratio M–H, random, 95% CI | |
| 3 | Randomised trials | Not serious | Not serious | Not serious | Seriousa | None | 149/201 (74.1%) | 149/197 (75.6%) | RR 0.96 (0.77–1.19) | 30 fewer per 1000 (from 174 fewer to 144 more) | 0.96 [0.77, 1.19] | ⊕⊕⊕◯ MODERATE |
| 4 | Randomised trials | Not serious | Not serious | Not serious | Seriousa | None | 131/241 (54.4%) | 148/237 (62.4%) | RR 0.86 (0.72–1.02) | 87 fewer per 1000 (from 175 fewer to 12 more) | 0.86 [0.72, 1.02] | ⊕⊕⊕◯ MODERATE |
| 7 | Randomised trials | Not serious | Not serious | Not serious | Seriousa | NONE | 147/370 (39.7%) | 173/367 (47.1%) | RR 0.91 (0.73–1.13) | 42 fewer per 1000 (from 127 fewer to 61 more) | 0.91 [0.73, 1.13] | ⊕⊕⊕◯ MODERATE |
| 6 | Randomised trials | Not serious | Not serious | Not serious | Seriousa | None | 95/320 (29.7%) | 101/317 (31.9%) | RR 0.94 (0.74 to 1.18) | 19 fewer per 1000 (from 83 fewer to 57 more) | 0.94 [0.74, 1.18] | ⊕⊕⊕◯ MODERATE |
| 3 | Randomised trials | Not serious | Not serious | Not serious | Seriousa | None | 83/214 (38.8%) | 94/216 (43.5%) | RR 0.89 (0.72 to 1.11) | 48 fewer per 1000 (from 122 fewer to 48 more) | 0.89 [0.72, 1.11] | ⊕⊕⊕◯ MODERATE |
| 3 | Randomised trials | Not serious | Not serious | Not serious | Seriousa | None | 62/214 (29.0%) | 75/216 (34.7%) | RR 0.80 (0.51 to 1.25) | 69 fewer per 1000 (from 170 fewer to 87 more) | 0.80 [0.51, 1.25] | ⊕⊕⊕◯ MODERATE |
GRADE approach results in an assessment of the quality of a body of evidence High: Very confident that the true effect lies close to that of the estimate of the effect.
Moderate: Moderately confident in the effect estimate, the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low: Limited confidence in the effect estimate, the true effect may be substantially different from the estimate of the effect.
Very low: Little confidence in the effect estimate, the true effect is likely to be substantially different from the estimate of effect.
aThe confidence interval (CI) cross the clinical decision threshold between recommending and not recommending treatment.